Regenesis Biomedical is a medical device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy based medical device products and services that alleviate pain, restore health, and improve the quality of life. They envision their product, the Provant Therapy System to improve health and lead to a more active and fulfilling life.
The Provant Therapy System is FDA approved for the palliative treatment of post-operative pain and edema in superficial soft tissue. Post surgery, many tissues may be moved around or inflamed, but Provant helps reduce the pain by inducing endogenous opioids. This prescription only device exposes tissue to electromagnetic energy using an optimized energy pulse.
In a study of 2,877 patients: 97% were satisfied with Provant, 99.6% were satisfied with Regenesis’ service, 99.2% were able to operate Provant, and 96% would recommend Provant to others. With such a successful product Regenesis Biomedical has been accredited as an Exemplary Provider for Medicare beneficiaries. Since its initial launch into market, Provant has helped treat over 8500 patients and is approaching a $20 million run rate.
To learn about the next steps Regenesis Biomedical plans to take with this revolutionary pain management medical device, be sure to attend the 7th Annual OneMedForum in San Francisco from January 13th-15th